Fragile X Syndrome is a subset of autism whose cause is known. It is an identifiable genetic mutation, which results in reducing the communication within the brain and causes autistic like tendencies.
A team of researchers from the University of California – San Diego have discovered that a drug, Suramin, can be used to block cells’ responses to danger, and therefore allows them to begin to resume normal communication with one another. This reverses the symptoms of people with ASD caused by Fragile X Syndrome.
The drug has historically been used as an anti-parasitic drug, but this study, which has been published in Molecular Autism, has provided hope that a future treatment for Fragile X Syndrome is possible.
To read more on this, see here
Journal Reference: Jane C Naviaux, Lin Wang, Kefeng Li, A Taylor Bright, William A Alaynick, Kenneth R Williams, Susan B Powell and Robert K Naviaux. Antipurinergic therapy corrects the autism-like features in the fragile X (Fmr1 knockout) mouse model. Molecular Autism, 2015 DOI: 10.1186/2040-2392-6-1